首页> 外文期刊>The Korean journal of chemical engineering >Synthesis, recognition and evaluation of molecularly imprinted polymer nanoparticle using miniemulsion polymerization for controlled release and analysis of risperidone in human plasma samples
【24h】

Synthesis, recognition and evaluation of molecularly imprinted polymer nanoparticle using miniemulsion polymerization for controlled release and analysis of risperidone in human plasma samples

机译:细乳液聚合用于人血浆样品中利培酮的控释和分析的分子印迹聚合物纳米颗粒的合成,识别和评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We prepared high selective imprinted nanoparticle polymers by a miniemulsion polymerization technique, using risperidone as the template, MAA as the functional monomers, and TRIM as the cross-linker in acetonitrile as solvent. The morphology of the nanoparticles determined by scanning electron microscopy (SEM) images and drug release, binding properties and dynamic light scattering (DLS) of molecularly imprinted polymers (MIPs) were studied. Controlled release of risperidone from nanoparticles was investigated through in 1% wt sodium dodecyl sulfate aqueous solution and by measuring the absorbance by HPLC-UV. The results showed that the imprinted nanoparticles exhibited a higher binding level and slower release rate than non-imprinted nanoparticles, which contributed to interaction of risperidone with imprinted cavities within nanoparticles. Furthermore, the results from HPLC showed good precision (5% for 50.0 μg L~(-1)) and recoveries (between 86-91) using MIP from human plasma samples.
机译:我们通过微乳液聚合技术,以利培酮为模板,MAA为功能单体,TRIM为交联剂,在乙腈中制备高选择性印迹纳米颗粒聚合物。研究了通过扫描电子显微镜(SEM)图像确定的纳米颗粒的形态,分子印迹聚合物(MIP)的药物释放,结合特性和动态光散射(DLS)。通过在1%wt的十二烷基硫酸钠水溶液中以及通过HPLC-UV测量吸光度,研究了利培酮从纳米颗粒的控制释放。结果表明,压印纳米颗粒与非压印纳米颗粒相比具有更高的结合水平和更慢的释放速率,这有助于利培酮与纳米颗粒内压印腔的相互作用。此外,HPLC的结果显示出良好的精密度(50.0μgL〜(-1)为5%),并使用MIP从人血浆样品中回收(86-91之间)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号